|
|
|
|
Langerhans cell histiocytosis
|
| |
|
| |
Langerhans cell histiocytosis (LCH) is a rare disease involving clonal proliferation of Langerhans cells, abnormal cells deriving from bone marrow and capable of migrating from skin to lymph nodes. Clinically, its manifestations range from isolated bone lesions to multisystem disease.
LCH is part of a group of clinical syndromes called histiocytoses, which are characterized by an abnormal proliferation of histiocytes (an archaic term for activated dendritic cells and macrophages).

Discussion
Ask a question about 'Langerhans cell histiocytosis'
Start a new discussion about 'Langerhans cell histiocytosis'
Answer questions from other users
|
Encyclopedia
Langerhans cell histiocytosis (LCH) is a rare disease involving clonal proliferation of Langerhans cells, abnormal cells deriving from bone marrow and capable of migrating from skin to lymph nodes. Clinically, its manifestations range from isolated bone lesions to multisystem disease.
LCH is part of a group of clinical syndromes called histiocytoses, which are characterized by an abnormal proliferation of histiocytes (an archaic term for activated dendritic cells and macrophages). These diseases are related to other forms of abnormal proliferation of white blood cells, such as leukemias and lymphomas.
The disease had gone by several names, including Hans-Schüller-Christian disease, Letterer-Siwe disease, and histiocytosis X, until it was renamed in 1985 by the Histiocyte Society.
Classification
| Alternative names |
|---|
| Histiocytosis X
Histiocytosis X syndrome | | Subordinate terms | Hand-Schüller-Christian disease
Letterer-Siwe disease
Histiocytosis X, unspecified
Eosinophilic granulomatosis
Langerhans cell granulomatosis
Langerhans cell histiocytosis, Hashimoto-Pritzker type
Langerhans cell histiocytosis of lung
Langerhans cell histiocytosis, disseminated (clinical)
Langerhans cell histiocytosis, unifocal (clinical) |
The disease spectrum results from clonal accumulation and proliferation of cells resembling the epidermal dendritic cells called Langerhans cells, hence sometimes called dendritic cell histiocytosis. These cells in combination with lymphocytes, eosinophils, and normal histiocytes form typical LCH lesions that can be found in almost any organ.
There are three types of histiocytoses: malignant (true histiocytic lymphomas), "reactive" (benign histiocytoses), Langerhans cell histiocytosis.
"Reactive" in this context indicates that the abnormality may be due to a physiological reaction to infection. For example leukocytosis (proliferation of white blood cells) is a normal reaction to infection, and "histiocytes" are developmentally related to white blood cells.
LCH is traditionally divided into three groups: unifocal, multifocal unisystem, and multifocal multisystem.
Unifocal
- Unifocal LCH, also called eosinophilic granuloma, is a slowly-progressing disease characterized by an expanding proliferation of Langerhans cells in various bones, the skin, the lungs, or the stomach..
Multifocal unisystem
- Seen mostly in children, multifocal unisystem LCH is characterized by fever, bone lesions and diffuse eruptions, usually on the scalp and in the ear canals. 50% of cases involve the pituitary stalk, leading to diabetes insipidus. The triad of diabetes insipidus, exopthalmos, and lytic bone lesions is known as the Hand-Schüller-Christian triad.
Multifocal multisystem
- Multifocal multisystem LCH, also called Letterer-Siwe disease, is a rapidly-progressing disease in which Langerhans cells proliferate in many tissues. It is mostly seen in children under age 2, and the prognosis is poor: even with aggressive chemotherapy, the 5-year survival is only 50%; however, this may be improved with new treatment protocols.
Pulmonary Langerhans cell histiocytosis (PLCH) is a smoking-related interstitial lung disease. It was once considered a benign condition in adults, but long term complications like pulmonary hypertension are becoming increasingly recognized.
Prevalence
LCH usually affects children between 1 and 15 years old, with a peak incidence between 5 and 10 years of age. Among children under the age of 10, yearly incidence is thought to be 1 in 200,000; and in adults even more rare, in about 1 in 560,000. It has been reported in elderly but is vanishingly rare. It is most prevalent in Caucasians, and affects males twice as often as females.
LCH is usually a sporadic and non-hereditary condition but familial clustering has been noted in limited number of cases. Hashimoto-Pritzker disease is a congenital self-healing variant of Hand-Schüller-Christian disease.
Signs and symptoms LCH provokes a non-specific inflammatory response, which includes fever, lethargy, and weight loss. Organ involvement can also cause more specific symptoms.
- Bone: The most-frequently seen symptom in both unifocal and multifocal disease is painful bone swelling. The skull is most frequently-affected, followed by the long bones of the upper extremities and flat bones. Infiltration in hands and feet is unusual. Osteolytic lesions can lead to pathological fractures.
- Skin: Commonly seen are a rash which varies from scaly erythematous lesions to red papules pronounced in intertriginous areas. Up to 80% of LCH patients have extensive eruptions on the scalp.
- Bone marrow: Pancytopenia with super-added infection usually implies a poor prognosis. Anemia can be due to number of factors and not necessarily implies bone marrow infiltration.
- Lymph node: Enlargement of the liver in 20%, spleen in 30% and lymph nodes in 50% of histiocytosis cases.
- Endocrine glands: Hypothalamic pituitary axis commonly involved. Diabetes insipidus most common. Anterior pituitary hormone deficiency is usually permanent.
- Lungs
- Less frequently GIT, CNS.
Diagnosis
Diagnosis is confirmed histologically by tissue biopsy. Hematoxylin-eosin stain of biopsy slide will show features of Langerhans cell e.g. distinct cell margin, pink granular cytoplasm. Presence of Birbeck granules on electron microscopy and immuno-cytochemical features e. g. CD1 positivity are more specific. Initially routine blood tests e.g. full blood count, liver function test, U&Es, bone profile are done to determine disease extent and rule out other causes. Radiology will show osteolytic bone lesions and damage to the lung. Latter may be evident in CXR with micronodular and interstitial infiltrate in the mid and lower zone of lung, with sparing of the Costophrenic angle or honeycomb appearance in older lesions. MRI and CT may show infiltration in sella turcica. Assessment of endocrine function and bonemarrow biopsy are also performed when on.
Treatment
Treatment is guided by extent of disease. Solitary bone lesion may be amenable through excision or limited radiation. However systemic disease often require chemotherapy. Use of systemic steroid is common, singly or adjunct to chemotherapy. Local steroid cream is applied to skin lesions. Endocrine deficiency often require lifelong supplement e.g. desmopressin for diabates insipidus which can be applied as nasal drop. Chemotherapeutic agents such as alkylating agents, antimetabolites, vinca alkaloids either singly or in combination can lead to complete remission in diffuse DISEASE.
Prognosis
Excellent for single foci disease. With multi-focal disease 60% have a chronic course, 30% achieve remission and mortality is up to 10%.
LCH in popular culture
- LCH was featured in Merry Little Christmas, an episode of the TV series House.
- A patient was diagnosed with Eosinophilic granuloma in Alone, another House episode.
See also
External links
MedPix(r)Database
, article by the Sydney Children's Hospital
|
| |
|
|